Real-world experience of rifampicin sparing treatment for drug-susceptible pulmonary tuberculosis

被引:0
|
作者
Kim, Hyung-Jun [1 ,2 ]
Song, Myung Jin [1 ,2 ]
Kwon, Byoung Soo [1 ,2 ]
Kim, Yeon Wook [1 ,2 ]
Lim, Sung Yoon [1 ,2 ]
Lee, Yeon-Joo [1 ,2 ]
Park, Jong Sun [1 ,2 ]
Cho, Young-Jae [1 ,2 ]
Lee, Choon-Taek [1 ,2 ]
Lee, Jae Ho [1 ,2 ]
机构
[1] Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
AO04-7
引用
收藏
页码:36 / 36
页数:1
相关论文
共 50 条
  • [1] Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis
    Kim, Hyung-Jun
    Lee, Ye Jin
    Song, Myung Jin
    Kwon, Byoung Soo
    Kim, Yeon Wook
    Lim, Sung Yoon
    Lee, Yeon-Joo
    Park, Jong Sun
    Cho, Young-Jae
    Lee, Choon-Taek
    Lee, Jae Ho
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis
    Hyung-Jun Kim
    Ye Jin Lee
    Myung Jin Song
    Byoung Soo Kwon
    Yeon Wook Kim
    Sung Yoon Lim
    Yeon-Joo Lee
    Jong Sun Park
    Young-Jae Cho
    Choon-Taek Lee
    Jae Ho Lee
    Scientific Reports, 13
  • [3] Treatment of Drug-Susceptible Tuberculosis
    Dela Cruz, Charles S.
    Lyons, Patrick G.
    Pasnick, Susan
    Weinstock, Tanya
    Nahid, Payam
    Wilson, Kevin C.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (11) : 2060 - 2063
  • [4] Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
    Vincent K. Chang
    Marjorie Z. Imperial
    Patrick P. J. Phillips
    Gustavo E. Velásquez
    Payam Nahid
    Andrew Vernon
    Ekaterina V. Kurbatova
    Susan Swindells
    Richard E. Chaisson
    Susan E. Dorman
    John L. Johnson
    Marc Weiner
    Erin E. Sizemore
    William Whitworth
    Wendy Carr
    Kia E. Bryant
    Deron Burton
    Kelly E. Dooley
    Melissa Engle
    Pheona Nsubuga
    Andreas H. Diacon
    Nguyen Viet Nhung
    Rodney Dawson
    Radojka M. Savic
    Nature Communications, 15 (1)
  • [5] Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China
    WANG Ni
    MA Yan
    LIU YU Hong
    DU Jian
    ZHANG Hui
    XIE Shi Heng
    Zhu Kun
    LYU Xiao Ya
    SHU Wei
    WANG Hong Hong
    ZHU Guo Feng
    TAN Shou Yong
    FU Yan Yong
    MA Li Ping
    ZHANG Lian Ying
    LIU Fei Ying
    HU Dai Yu
    ZHANG Yan Ling
    LI Xiang Qun
    LI Liang
    Biomedical and Environmental Sciences, 2016, 29 (08) : 612 - 617
  • [6] New Regimens for Reducing the Duration of Treatment of Drug-Susceptible Pulmonary Tuberculosis
    Conde, Marcus B.
    Lapa e Silva, Jose R.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (06) : 501 - 508
  • [7] Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China
    Wang Ni
    Ma Yan
    Liu Yu Hong
    Du Jian
    Zhang Hui
    Xie Shi Heng
    Zhu Kun
    Lyu Xiao Ya
    Shu Wei
    Wang Hong Hong
    Zhu Guo Feng
    Tan Shou Yong
    Fu Yan Yong
    Ma Li Ping
    Zhang Lian Ying
    Liu Fei Ying
    Hu Dai Yu
    Zhang Yan Ling
    Li Xiang Qun
    Li Liang
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2016, 29 (08) : 612 - 617
  • [8] A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis
    Naidoo, Anushka
    Naidoo, Kogieleum
    McIlleron, Helen
    Essack, Sabiha
    Padayatchi, Nesri
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1369 - 1386
  • [9] Isoniazid and rifampicin exposure during treatment in drug-susceptible TB
    Akkerman, O. W.
    Dijkwel, R. D. C.
    Kerstjens, H. A. M.
    van der Werf, T. S.
    Srivastava, S.
    Sturkenboom, M. G. G.
    Bolhuis, M. S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (10) : 772 - 777
  • [10] Treatment Interruption Among Drug-Susceptible Pulmonary Tuberculosis Patients in Southern Ethiopia
    Workie, Moges Getie
    Aycheh, Moges Wubie
    Birhanu, Molla Yigzaw
    Tsegaye, Tesfa Birlew
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 1143 - 1151